Pharma

Volvo Sold 11,742 Passenger Vehicles In Mainland China In Jan

  • February 03, 2023 02:42 PM CET | Reuters
 Volvo Sold 11,742 Passenger Vehicles In Mainland China In Jan

Feb 3 (Reuters) - Volvo Car AB: * CO HAS SOLD 11,742 PASSENGER VEHICLES IN MAINLAND CHINA IN JAN Source text Further company coverage: (Reporting by Hong Kong newsroom. Editing by Jane Merriman)

Read More...
Biogaia Proposes Ordinary Dividend Of SEK 1.45 Per Share

Biogaia Proposes Ordinary Dividend Of SEK 1.45 Per Share

  • February 03, 2023 08:05 AM CET | Reuters

Feb 3 (Reuters) - Biogaia AB: * BOARD PROPOSES THAT UPCOMING ANNUAL GENERAL MEETING ON 5 MAY 2023 APPROVES AN ORDINARY DIVIDEND ACCORDING TO POLICY OF SEK 1.45 (0.73) PER SHARE * BOARD PROPOSES AN

Read More...
Orexo Submits New Drug Application To FDA For OX124, High-Dose Rescue Medication For Opioid Overdose

Orexo Submits New Drug Application To FDA For OX124, High-Dose Rescue Medication For Opioid Overdose

  • February 03, 2023 08:04 AM CET | Reuters

Feb 3 (Reuters) - Orexo AB: * OREXO SUBMITS NEW DRUG APPLICATION TO FDA FOR OX124, A HIGH-DOSE RESCUE MEDICATION FOR OPIOID OVERDOSE * OX124 IS DESIGNED TO REVERSE EFFECTS OF MOST POWERFUL SYNTHETIC

Read More...
Amgen's Tezspire gets FDA Approval  For Self-Administration For Patients With Severe Asthma

Amgen's Tezspire gets FDA Approval For Self-Administration For Patients With Severe Asthma

  • February 02, 2023 03:33 PM CET | Reuters

Feb 2 (Reuters) - Amgen Inc: * AMGEN - ANNOUNCED FDA APPROVED TEZSPIRE FOR SELF-ADMINISTRATION IN PRE-FILLED, SINGLE-USE PEN FOR PATIENTS AGED 12 YEARS & OLDER WITH SEVERE ASTHMA * AMGEN INC - FDA HAS

Read More...
AstraZeneca Says Tezspire Approved For Self-Administration In US With New Pre-Filled Pen

AstraZeneca Says Tezspire Approved For Self-Administration In US With New Pre-Filled Pen

  • February 02, 2023 03:04 PM CET | Reuters

Feb 2 (Reuters) - AstraZeneca PLC: * ASTRAZENECA - TEZSPIRE APPROVED FOR SELF-ADMINISTRATION IN US WITH A NEW PRE-FILLED PEN Source text for Eikon: Further company coverage:

Read More...
Cantargia Appoints Patrik Renblad As CFO

Cantargia Appoints Patrik Renblad As CFO

  • February 01, 2023 03:44 PM CET | Reuters

Feb 1 (Reuters) - Cantargia AB: * CANTARGIA ANNOUNCES APPOINTMENT OF PATRIK RENBLAD AS CHIEF FINANCIAL OFFICER * MR RENBLAD WILL ASSUME THIS ROLE BY AUGUST 2023, AT LATEST. Source text for Eikon:

Read More...
Isofol Obtains Request To Call For EGM

Isofol Obtains Request To Call For EGM

  • January 30, 2023 01:51 PM CET | Reuters

Jan 30 (Reuters) - Isofol Medical AB (publ): * ISOFOL HAS OBTAINED A REQUEST TO CALL FOR AN EXTRAORDINARY GENERAL MEETING * OBTAINED A REQUEST TO CALL AN EXTRAORDINARY GENERAL MEETING TO ELECT A NEW

Read More...
Active Biotech Confirms Positive Clinical Safety Profile Of Laquinimod Eye Drops

Active Biotech Confirms Positive Clinical Safety Profile Of Laquinimod Eye Drops

  • January 30, 2023 08:49 AM CET | Reuters

Jan 30 (Reuters) - Active Biotech AB publ: * ACTIVE BIOTECH CONFIRMS POSITIVE CLINICAL SAFETY PROFILE OF LAQUINIMOD EYE DROPS * NO SERIOUS ADVERSE EVENTS WERE REPORTED. * EYE DROP WAS SAFE AND WELL

Read More...
Index Pharmaceuticals Updates Timeline Of Phase III Study CONCLUDE

Index Pharmaceuticals Updates Timeline Of Phase III Study CONCLUDE

  • January 27, 2023 01:43 PM CET | Reuters

Jan 27 (Reuters) - InDex Pharmaceuticals Holding AB : * INDEX PHARMACEUTICALS UPDATES THE TIMELINE OF THE PHASE III STUDY CONCLUDE WITH COBITOLIMOD * OUTCOME OF DOSE SELECTION EXPECTED TO BE AVAILABLE

Read More...
Devyser Makes Provisions Due To Retroactive

Devyser Makes Provisions Due To Retroactive "Payback" Levy

  • January 27, 2023 12:40 PM CET | Reuters

Jan 27 (Reuters) - Devyser Diagnostics AB: * DEVYSER MAKES PROVISIONS DUE TO RETROACTIVE "PAYBACK" LEVY * DUE TO NEWLY-INTRODUCED "PAYBACK" LEVY IN ITALY, COMPANY WILL MAKE PROVISIONS FOR ITS COSTS IN

Read More...
Intellego Technologies Dosimeter Tested By Drug Manufacturer

Intellego Technologies Dosimeter Tested By Drug Manufacturer

  • January 27, 2023 09:37 AM CET | Reuters

Jan 27 (Reuters) - Intellego Technologies AB: * CO'S DOSIMETER TESTED BY DRUG MANUFACTURER WITH POSITIVE RESULTS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Read More...

Frequently Asked Questions

3232